MinDNET digital platform strategy
From Idea to Operation
MiNDNET supports the entire development process of a digital therapeutic. This includes consulting, conception, production of clickable prototypes, minimal viable products and market-ready digital therapeutics, validation through qualitative and randomized controlled trials, market approval and operation.
We advise you on all key aspects of digital health applications including health policy situation, evidence-based development, market and competition analysis, possible business models, and market introduction.
We support the entire conception of the digital therapeutic including evidence-based fundamentals regarding guideline-based treatment and digital therapy, creation of a therapy concept, personas and customer Journeys.
Clickable prototypes give an initial impression of the functions and content of the digital therapeutic. Customers can thus experience and precisely understand the functions and content of the digital health application. It can be used to obtain feedback from experts and sufferers and to conduct market research.
Minimal viable product
A Minimal Viable Product (MVP) is a product with enough features to validate the product early in the product development cycle. MVP can help the product team get user feedback as quickly as possible to iterate and improve the product_ Together with our partner universities, we also conduct qualitative pilot studies with patients and professionals. Here, above all, the applicability is tested and used directly to improve the MVP.
Market-ready digital therapeutics
Market-ready digital therapeutics have gone through the development steps and meet all specifications regarding data protection and quality assurance. They can be provisionally approved. Regulatory studies can be conducted with them.
With our university partners, we conduct randomized controlled trials on the efficacy and safety of the digital therapeutic. Here, we have over 25 years of experience and have conducted over 50 large PCTs within our university background. Our two partner universities in Hamburg and Bern have over 300 study publications on digital therapeutics.
We support the approval process of the digital therapeutic or carry it out ourselves. This also includes preparing all documents or conducting price negotiations with the regulatory authority.
Physicians prescribe and patients use our digital therapeutics, while we gain and apply real-world Insights to continuously Improve the applications.